Literature DB >> 16775371

Intermediate forms of Charcot-Marie-Tooth neuropathy: a review.

Garth Nicholson1, Simon Myers.   

Abstract

The Charcot-Marie-Tooth (CMT) neuropathies divide into two main electrophysiological groups with slow and near normal conduction velocities corresponding to Schwann cell and axonal pathology. An intermediate group also exists with nerve conduction velocities, which overlaps the two main groups. Families with intermediate CMT can be recognized in which different affected individuals in the same family have motor conduction velocities in both the CMT type 1 and 2 ranges (i.e., above and below 38 m/s). The intermediate group is caused by a limited number of distinct gene mutations in dynamin2 (DNM2), gap-junction protein 1 (GJB1), neurofilament light polypeptide (NF-L) genes, and a rare mutation and as yet unknown genes on chromosome 1 and 10 loci. Intermediate forms of CMT may be associated with unique disease mechanisms affecting both Schwann cells and axons. It is useful to recognize this unique group of neuropathies for diagnostic and management purposes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775371     DOI: 10.1385/nmm:8:1-2:123

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  49 in total

Review 1.  Dynamin and its role in membrane fission.

Authors:  J E Hinshaw
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

Review 2.  Regulation of connexin biosynthesis, assembly, gap junction formation, and removal.

Authors:  Dominique Segretain; Matthias M Falk
Journal:  Biochim Biophys Acta       Date:  2004-03-23

3.  Motor nerve conduction velocity in peroneal muscular atrophy: evidence for genetic heterogeneity.

Authors:  P K Thomas; D B Calne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-01       Impact factor: 10.154

4.  Transient expression of the neurofilament proteins NF-L and NF-M by Schwann cells is regulated by axonal contact.

Authors:  C Fabrizi; B M Kelly; C S Gillespie; W W Schlaepfer; S S Scherer; P J Brophy
Journal:  J Neurosci Res       Date:  1997-10-15       Impact factor: 4.164

5.  The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease.

Authors:  Ana Cuesta; Laia Pedrola; Teresa Sevilla; Javier García-Planells; María José Chumillas; Fernando Mayordomo; Eric LeGuern; Ignacio Marín; Juan J Vílchez; Francesc Palau
Journal:  Nat Genet       Date:  2001-12-17       Impact factor: 38.330

6.  The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies. Part 2. Observations on pathological changes in sural nerve biopsies.

Authors:  R Madrid; W G Bradley; C J Davis
Journal:  J Neurol Sci       Date:  1977-05       Impact factor: 3.181

7.  Neurofilament transport in vivo minimally requires hetero-oligomer formation.

Authors:  Aidong Yuan; Mala V Rao; Asok Kumar; Jean-Pierre Julien; Ralph A Nixon
Journal:  J Neurosci       Date:  2003-10-15       Impact factor: 6.167

8.  Refined localization of dominant intermediate Charcot-Marie-Tooth neuropathy and exclusion of seven known candidate genes in the region.

Authors:  Danqing Zhu; Marina Kennerson; John Merory; Roman Chrast; Mark Verheijen; Greg Lemke; Garth Nicholson
Journal:  Neurogenetics       Date:  2003-05-22       Impact factor: 2.660

9.  Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35.

Authors:  Albena Jordanova; Florian P Thomas; Velina Guergueltcheva; Ivailo Tournev; Francisco A A Gondim; Borjana Ishpekova; Els De Vriendt; An Jacobs; Ivan Litvinenko; Neviana Ivanova; Borjan Buzhov; Peter De Jonghe; Ivo Kremensky; Vincent Timmerman
Journal:  Am J Hum Genet       Date:  2003-11-06       Impact factor: 11.025

10.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

View more
  29 in total

1.  Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.

Authors:  Heather M McLaughlin; Reiko Sakaguchi; Cuiping Liu; Takao Igarashi; Davut Pehlivan; Kristine Chu; Ram Iyer; Pedro Cruz; Praveen F Cherukuri; Nancy F Hansen; James C Mullikin; Leslie G Biesecker; Thomas E Wilson; Victor Ionasescu; Garth Nicholson; Charles Searby; Kevin Talbot; Jeffrey M Vance; Stephan Züchner; Kinga Szigeti; James R Lupski; Ya-Ming Hou; Eric D Green; Anthony Antonellis
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

2.  NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.

Authors:  José Berciano; Antonio García; Kristien Peeters; Elena Gallardo; Els De Vriendt; Ana L Pelayo-Negro; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

3.  A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).

Authors:  Heather M McLaughlin; Reiko Sakaguchi; William Giblin; Thomas E Wilson; Leslie Biesecker; James R Lupski; Kevin Talbot; Jeffery M Vance; Stephan Züchner; Yi-Chung Lee; Marina Kennerson; Ya-Ming Hou; Garth Nicholson; Anthony Antonellis
Journal:  Hum Mutat       Date:  2011-11-09       Impact factor: 4.878

4.  Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot-Marie-Tooth neuropathy.

Authors:  Erik Storkebaum; Ricardo Leitão-Gonçalves; Tanja Godenschwege; Leslie Nangle; Monica Mejia; Inge Bosmans; Tinne Ooms; An Jacobs; Patrick Van Dijck; Xiang-Lei Yang; Paul Schimmel; Koen Norga; Vincent Timmerman; Patrick Callaerts; Albena Jordanova
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-26       Impact factor: 11.205

Review 5.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

6.  Clinical, neurophysiological and morphological study of dominant intermediate Charcot-Marie-Tooth type C neuropathy.

Authors:  Florian P Thomas; Velina Guergueltcheva; Francisco A A Gondim; Ivailo Tournev; Chitharanjan V Rao; Boryana Ishpekova; Laurence J Kinsella; Yi Pan; Thomas J Geller; Ivan Litvinenko; Peter De Jonghe; Steven S Scherer; Albena Jordanova
Journal:  J Neurol       Date:  2016-01-02       Impact factor: 4.849

7.  Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation.

Authors:  Elena Gallardo; Kristl G Claeys; Eva Nelis; Antonio García; Ana Canga; Onofre Combarros; Vincent Timmerman; Peter De Jonghe; José Berciano
Journal:  J Neurol       Date:  2008-06-17       Impact factor: 4.849

8.  Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy.

Authors:  Claudia Gonzaga-Jauregui; Tamar Harel; Tomasz Gambin; Maria Kousi; Laurie B Griffin; Ludmila Francescatto; Burcak Ozes; Ender Karaca; Shalini N Jhangiani; Matthew N Bainbridge; Kim S Lawson; Davut Pehlivan; Yuji Okamoto; Marjorie Withers; Pedro Mancias; Anne Slavotinek; Pamela J Reitnauer; Meryem T Goksungur; Michael Shy; Thomas O Crawford; Michel Koenig; Jason Willer; Brittany N Flores; Igor Pediaditrakis; Onder Us; Wojciech Wiszniewski; Yesim Parman; Anthony Antonellis; Donna M Muzny; Nicholas Katsanis; Esra Battaloglu; Eric Boerwinkle; Richard A Gibbs; James R Lupski
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

9.  Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.

Authors:  Elizabeth M Gibbs; Nigel F Clarke; Kristy Rose; Emily C Oates; Richard Webster; Eva L Feldman; James J Dowling
Journal:  J Mol Med (Berl)       Date:  2013-01-22       Impact factor: 4.599

10.  NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.

Authors:  José Berciano; Kristien Peeters; Antonio García; Tomás López-Alburquerque; Elena Gallardo; Arantxa Hernández-Fabián; Ana L Pelayo-Negro; Els De Vriendt; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.